Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

被引:181
作者
Andrade, Stephanie [1 ]
Ramalho, Maria Joao [1 ]
Loureiro, Joana Angelica [1 ]
Pereira, Maria do Carmo [1 ]
机构
[1] Univ Porto, Dept Chem Engn, LEPABE, Fac Engn, P-4200465 Porto, Portugal
关键词
neurodegenerative disease; bioactive compound; natural extract; -amyloid peptide; tau protein; clinical trial; human studies; animal studies; in vitro studies; AMYLOID PRECURSOR PROTEIN; GINKGO-BILOBA EXTRACT; MILD COGNITIVE IMPAIRMENT; TRANSGENIC MOUSE MODEL; BLOOD-BRAIN-BARRIER; AUSTRALIAN MARINE SPONGE; 13-DESMETHYL SPIROLIDE-C; REDUCES OXIDATIVE STRESS; PLACEBO-CONTROLLED TRIAL; IN-VITRO MODEL;
D O I
10.3390/ijms20092313
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Alzheimer's Disease (AD) is a neurodegenerative disorder related with the increase of age and it is the main cause of dementia in the world. AD affects cognitive functions, such as memory, with an intensity that leads to several functional losses. The continuous increase of AD incidence demands for an urgent development of effective therapeutic strategies. Despite the extensive research on this disease, only a few drugs able to delay the progression of the disease are currently available. In the last years, several compounds with pharmacological activities isolated from plants, animals and microorganisms, revealed to have beneficial effects for the treatment of AD, targeting different pathological mechanisms. Thus, a wide range of natural compounds may play a relevant role in the prevention of AD and have proven to be efficient in different preclinical and clinical studies. This work aims to review the natural compounds that until this date were described as having significant benefits for this neurological disease, focusing on studies that present clinical trials.
引用
收藏
页数:41
相关论文
共 353 条
[1]
Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2/insulin-like signaling pathway [J].
Abbas, S. ;
Wink, M. .
PHYTOMEDICINE, 2010, 17 (11) :902-909
[2]
Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice [J].
Ahmad, Ashfaq ;
Ali, Tahir ;
Park, Hyun Young ;
Badshah, Haroon ;
Rehman, Shafiq Ur ;
Kim, Myeong Ok .
MOLECULAR NEUROBIOLOGY, 2017, 54 (03) :2269-2285
[3]
Neuroprotection by Vitamin C Against Ethanol-Induced Neuroinflammation Associated Neurodegeneration in the Developing Rat Brain [J].
Ahmad, Ashfaq ;
Shah, Shahid A. ;
Badshah, Haroon ;
Kim, Min J. ;
Ali, Tahir ;
Yoon, Gwang H. ;
Kim, Tae H. ;
Abid, Nouman B. ;
Rehman, Shafiq Ur ;
Khan, Sohail ;
Kim, Myeong O. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (03) :360-370
[4]
Ahmed AH, 2014, CURR ALZHEIMER RES, V11, P834
[5]
Resveratrol and Alzheimer's Disease: Mechanistic Insights [J].
Ahmed, Touqeer ;
Javed, Sehrish ;
Javed, Sana ;
Tariq, Ameema ;
Samec, Dunja ;
Tejada, Silvia ;
Nabavi, Seyed Fazel ;
Braidy, Nady ;
Nabavi, Seyed Mohammad .
MOLECULAR NEUROBIOLOGY, 2017, 54 (04) :2622-2635
[6]
Natural Compounds against Alzheimer's Disease: Molecular Recognition of Aβ1-42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMR [J].
Airoldi, Cristina ;
Sironi, Erika ;
Dias, Catarina ;
Marcelo, Filipa ;
Martins, Alice ;
Rauter, Amelia Pilar ;
Nicotra, Francesco ;
Jimenez-Barbero, Jesus .
CHEMISTRY-AN ASIAN JOURNAL, 2013, 8 (03) :596-602
[7]
A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease [J].
Aisen, P. S. ;
Saumier, D. ;
Briand, R. ;
Laurin, J. ;
Gervais, F. ;
Tremblay, P. ;
Garceau, D. .
NEUROLOGY, 2006, 67 (10) :1757-1763
[8]
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study) [J].
Aisen, Paul S. ;
Gauthier, Serge ;
Ferris, Steven H. ;
Saumier, Daniel ;
Haine, Denis ;
Garceau, Denis ;
Anh Duong ;
Suhy, Joyce ;
Oh, Joonmi ;
Lau, Wan C. ;
Sampalis, John .
ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (01) :102-111
[9]
Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid β protein [J].
Akaishi, Tatsuhiro ;
Morimoto, Takeo ;
Shibao, Mami ;
Watanabe, Sayaka ;
Sakai-Kato, Kumiko ;
Utsunomiya-Tate, Naoko ;
Abe, Kazuho .
NEUROSCIENCE LETTERS, 2008, 444 (03) :280-285
[10]
Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomised, placebo controlled trial [J].
Akhondzadeh, S ;
Noroozian, M ;
Mohammadi, M ;
Ohadinia, S ;
Jamshidi, AH ;
Khani, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (07) :863-866